Tudóstér: Majoros László publikációi

Kovács, R., Árokszállási, T., Bozó, A., Jakab, Á., Bábel, K., Héja, M., Kovács, K., Balázs, B., Vitális, E., Majoros, L., Tóth, Z.: Bacteraemia Associated with Bilophila wadsworthia: a Rare Case Presentation from Hungary.
Pathogens. 13 (9), 1-7, 2024.

Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á., Nagy, F., Borman, A., Majoros, L., Kovács, R.: Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. 12 (4), 1-12, 2024.

Kovács, F., Balla, N., Bozó, A., Harmath, A., Jakab, Á., Tóth, Z., Nagy, F., Majoros, L., Kovács, R.: Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, 2024.

Domán, M., Kaszab, E., Laczkó, L., Bali, K., Makrai, L., Kovács, R., Majoros, L., Bányai, K.: Genomic epidemiology of antifungal resistance in human and avian isolates of Candida albicans: a pilot study from the One Health perspective.
Front. Vet. Sci. 11 1-7, 2024.

Balázsi, D., Tóth, Z., Locke, J., Borman, A., Forgács, L., Balla, N., Kovács, F., Kovács, R., Amano, C., Baran, T., Majoros, L.: In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model.
J. Fungi. 10 (9), 1-14, 2024.

Kovács, F., Balla, N., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: Impact of n-acyl-homoserine lactone, quorum sensing molecule, on candida auris isolates.
Acta Microbiol. Immunol. Hung. 70 (Supplement), 30-31, 2023.

Adnan, A., Borman, A., Tóth, Z., Forgács, L., Kovács, R., Balázsi, D., Balázs, B., Udvarhelyi, G., Kardos, G., Majoros, L.: In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades.
Pharmaceutics. 15 (5), 1-16, 2023.

Balla, N., Kovács, F., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: The effect of caspofungin in combination with posaconazole against echinocandin susceptible and resistant candida auris isolates.
Acta Microbiol. Immunol. Hung. 70 (Supplement), 6-7, 2023.

Tóth, Z., Bozó, A., Kovács, R., Balogh, B., Balázs, B., Forgács, L., Kelentey, B., Majoros, L.: The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
Mycopathologia. 188 (1-2), 111-118, 2023.

Balla, N., Jakab, Á., Kovács, F., Ragyák, Á., Tóth, Z., Balázsi, D., Forgács, L., Bozó, A., Al Refai, F., Borman, A., Majoros, L., Kovács, R.: Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol.
AMB Express. 13 (1), 1-10, 2023.

Kovács, R., Kovács, F., Balla, N., Ragyák, Á., Sajtos, Z., Majoros, L., Jakab, Á.: Transcriptional changes and related physiological effect caused by tyrosol exposure in Candida auris.
In: ECFG16 abstractbook, PCO Tyrol Congress, Innsbruck, 425-426, 2023.

Kovács, R., Majoros, L., Stemler, J., Cornely, O., Salmanton-García, J.: Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
Therapeutic Advances in Infection. [Epub ahead of print]2023.

Kovács, R., Majoros, L.: Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?.
Lett. Appl. Microbiol. 74 (6), 851-862, 2022.

Nagy, J., Balázs, B., Benmazouz, I., Gyüre, P., Kövér, L., Kaszab, E., Bali, K., Lovas-Kiss, Á., Damjanova, I., Majoros, L., Tóth, Á., Bányai, K., Kardos, G.: Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective.
Front. Microbiol. 12 1-9, 2022.

Balázs, B., Tóth, Z., Nagy, J., Majoros, L., Tóth, Á., Kardos, G.: Faecal Carriage of Carbapenem-Resistant Acinetobacter baumannii: comparison to Clinical Isolates from the Same Period (2017-2019).
Pathogens. 11 (9), 1-9, 2022.

Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pfliegler, V., Pócsi, I.: Heme Oxygenase-1 (HMX1) Loss of Function Increases the In-Host Fitness of the Saccharomyces 'boulardii' Probiotic Yeast in a Mouse Fungemia Model.
J. Fungi. 8 (5), 522, 2022.

Forgács, L., Borman, A., Kovács, R., Balázsi, D., Tóth, Z., Balázs, B., Chun-Ju, C., Kardos, G., Kovács, I., Majoros, L.: In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.
J. Fungi. 8 (5), 1-16, 2022.

Jakab, Á., Kovács, F., Balla, N., Tóth, Z., Ragyák, Á., Sajtos, Z., Csillag, K., Nagy-Köteles, C., Nemes, D., Bácskay, I., Pócsi, I., Majoros, L., Kovács, Á., Kovács, R.: Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicans.
Biomed. Pharmacother. 152 1-10, 2022.

Balla, N., Kovács, F., Balázs, B., Borman, A., Bozó, A., Jakab, Á., Tóth, Z., Kobaissi, O., Majoros, L., Kovács, R.: Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms.
Antibiotics-Basel. 11 (11), 1-12, 2022.

Kovács, R., Balla, N., Kovács, F., Majoros, L., Jakab, Á.: Transcriptional response of Candida auris biofilms to farnesol and tyrosol treatment.
In: Eurobiofilms abstractbook, [s.n.], Palma de Mallorca, 143, 2022.

Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pócsi, I., Pfliegler, V.: Variability of the probiotic yeast saccharomyces cerevisiae var. `BOULARDII` in genome, phenotype, and virulence.
In: Biotechnology at the University of Debrecen - 2022 International Symposium : Abstarct Book, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Environmental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 38-39, 2022. ISBN: 9789634904687

Kovács, R., Tóth, Z., Locke, J., Forgács, L., Kardos, G., Nagy, F., Borman, A., Majoros, L.: Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, 2021.

Nagy, F., Tóth, Z., Váradi, G., Tóth, L., Forgács, L., Vadászi, K., Majoros, L., Galgóczy, L., Kovács, R.: Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68 28-29, 2021.

Tóth, H., Buchholcz, G., Fésüs, A., Balázs, B., Nagy, J., Majoros, L., Szarka, K., Kardos, G.: Evolution of the Gram-Negative Antibiotic Resistance Spiral over Time: a Time-Series Analysis.
Antibiotics-Basel. 10 (6), 1-10, 2021.

Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A., Majoros, L., Kovács, R.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.

Domán, M., Makrai, L., Lengyel, G., Kovács, R., Majoros, L., Bányai, K.: Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary.
Mycopathologia. 186 (2), 237-244, 2021.

Kovács, R., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G., Vadászi, K., Borman, A., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, 2021.

Balázs, B., Tóth, Z., Nagy, F., Kovács, R., Tóth, H., Nagy, J., Tóth, Á., Szarka, K., Majoros, L., Kardos, G.: The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, 2021.

Jakab, Á., Balla, N., Ragyák, Á., Nagy, F., Kovács, F., Sajtos, Z., Tóth, Z., Borman, A., Pócsi, I., Baranyai, E., Majoros, L., Kovács, R.: Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, 2021.

Kovács, R., Jakab, Á., Ragyák, Á., Sajtos, Z., Nagy, F., Baranyai, E., Pócsi, I., Majoros, L.: Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68 85, 2021.

Papp, Z., Borman, A., Forgács, L., Kovács, R., Tóth, Z., Chun-Ju, C., Kardos, G., Juhász, B., Szilvássy, J., Majoros, L.: Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades.
Pathogens. 10 (8), 1-11, 2021.

Imre, A., Kovács, R., Pázmándi, K., Nemes, D., Jakab, Á., Fekete, T., Rácz, H., Dóczi, I., Bácskay, I., Gácser, A., Kovács, K., Majoros, L., Farkas, Z., Pócsi, I., Pfliegler, V.: Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces 'boulardii').
J. Fungi. 7 (9), 1-29, 2021.

Nagy, M., Szemán-Nagy, G., Kiss, A., Nagy, Z., Tálas, L., Rácz, D., Majoros, L., Tóth, Z., Máthéné Szigeti, Z., Pócsi, I., Kéki, S.: Antifungal Activity of an Original Amino-Isocyanonaphthalene (ICAN) Compound Family: Promising Broad Spectrum Antifungals.
Molecules. 25 (4), 1-12, 2020.

Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.

Forgács, L., Borman, A., Prépost, E., Tóth, Z., Kardos, G., Kovács, R., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.

Kovács, R., Majoros, L.: Fungal Quorum-Sensing Molecules: a Review of Their Antifungal Effect against Candida Biofilms.
J. Fungi. 6 (3), 99, 2020.

Nagy, F., Vitális, E., Jakab, Á., Borman, A., Forgács, L., Tóth, Z., Majoros, L., Kovács, R.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11 1-12, 2020.

Tóth, Z., Forgács, L., Kardos, T., Kovács, R., Locke, J., Kardos, G., Nagy, F., Borman, A., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Borman, A., Majoros, L.: Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.

Prépost, E., Tóth, Z., Perlin, D., Gesztelyi, R., Kardos, G., Kovács, R., Nagy, F., Forgács, L., Majoros, L.: Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12 1805-1814, 2019.

Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A., Majoros, L., Kovács, R.: Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.

Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.

Forgács, L., Tóth, Z., Locke, J., Nagy, F., Balázs, B., Prépost, E., Kardos, G., Kovács, R., Székely, A., Borman, A., Majoros, L.: Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Székely, A., Borman, A., Majoros, L.: In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.

Kovács, R., Holzknecht, J., Hargitai, Z., Papp, C., Farkas, A., Borics, A., Tóth, L., Váradi, G., Tóth, G., Kovács, I., Dubrac, S., Majoros, L., Marx, F., Galgóczy, L.: In vivo applicability of Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment of vulvovaginal candidiasis.
Antimicrob. Agents Chemother. 63 (2), 1-12, 2019.

Váradi, J., Hermenean, A., Gesztelyi, R., Jeney, V., Balogh, E., Majoros, L., Malanga, M., Fenyvesi, É., Szente, L., Bácskay, I., Vecsernyés, M., Fehér, P., Ujhelyi, Z., Vasvári, G., Árvai, I., Rusznyák, Á., Balta, C., Herman, H., Fenyvesi, F.: Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin.
Biomolecules. 9 (10), 1-13, 2019.

Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., Kovács, R.: Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.: Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.

Nagy, F., Tóth, Z., Forgács, L., Borman, A., Majoros, L., Balázs, B., Kovács, R.: The effect of farnesol on Candida auris biofilms, virulence and azole susceptibility.
J. Fungi. 95 (5), 141-142, 2019.

Kovács, R., Nagy, F., Tóth, Z., Majoros, L.: The effect of nikkomycin Z in combination with echinocandins against Candida albicans and Candida parapsilosis biofilms.
Acta Microbiol. Immunol. Hung. 66 56-57, 2019.

Kovács, R., Jakab, Á., Tóth, Z., Nagy, F., Emri, T., Pócsi, I., Majoros, L.: Transcriptional and physiological effect exerted by tyrosol on Candida parapsilosis cells.
J. Fungi. 5 (95), 142-143, 2019.

Tóth, H., Fésüs, A., Kungler-Gorácz, O., Balázs, B., Majoros, L., Szarka, K., Kardos, G.: Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in Gram-negative bacteria from cephalosporin consumption to colistin resistance.
Clin. Infect. Dis. 69 (8), 1410-1421, 2019.

Tóth, Z., Kardos, T., Kovács, R., Kardos, G., Nagy, F., Prépost, E., Barta, Z., Takács, I., Majoros, L.: Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.

Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Majoros, L., Kovács, R.: In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Med. Mycol. 56 (4), 493-500, 2018.

Kardos, T., Kovács, R., Kardos, G., Varga, I., Bozó, A., Tóth, Z., Nagy, F., Majoros, L.: Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Majoros, L.: The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 56 S131, 2018.

Jakab, Á., Nagy, F., Tóth, Z., Nemes, D., Majoros, L., Bácskay, I., Pócsi, I., Kovács, R.: Tyrosol influences the physiology and virulence of Candida parapsilosis.
In: Fiatal Biotechnológusok Országos Konferenciája. Szerk.: Tamás László, Zelenyánszki Helga, JATEPress, Szeged, 95, 2018. ISBN: 9789633153703

Kovács, R., Tóth, Z., Nagy, F., Daróczi, L., Bozó, A., Majoros, L.: Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
J. Appl. Microbiol. 122 (6), 1529-1536, 2017.

Boros, E., Pfliegler, V., Kovács, R., Jakab, Á., Majoros, L., Barta, Z., Pócsi, I.: Candida albicans isolates from a single hospital show low phenotypical specialization.
J. Basic Microbiol. 57 (11), 910-921, 2017.

Pfliegler, V., Boros, E., Pázmándi, K., Jakab, Á., Zsuga, I., Kovács, R., Urbán, E., Antunovics, Z., Bácsi, A., Sipiczki, M., Majoros, L., Pócsi, I.: Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
Mol. Nutr. Food Res. 61 (11), 1601099-1 - 1601099-8, 2017.

Saleh, Q., Kovács, R., Kardos, G., Gesztelyi, R., Kardos, T., Bozó, A., Majoros, L.: Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
Microb. Drug Resist. 23 (6), 764-770, 2017.

Kovács, R., Saleh, Q., Bozó, A., Tóth, Z., Gesztelyi, R., Kardos, T., Kardos, G., Takács, I., Majoros, L.: Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 182 (11-12), 979-987, 2017.

Kardos, T., Saleh, Q., Kovács, R., Gesztelyi, R., Kardos, G., Bozó, A., Tóth, Z., Majoros, L.: Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
New Microbiol. 40 (4), 286-288, 2017.

Kovács, R., Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Kardos, G., Majoros, L.: The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
Acta Microbiol. Immunol. Hung. 62 152, 2017.

Ebrahimi, F., Mózes, J., Mészáros, J., Juhász, Á., Majoros, L., Szarka, K., Kardos, G.: Asymptomatic faecal carriage of ESBL producing Enterobacteriaceae in Hungarian healthy individuals and in long-term care applicants: a shift towards CTX-M producers in the community.
Infect. Dis. 48 (7), 557-559, 2016.

Ebrahimi, F., Mózes, J., Monostori, J., Kungler-Gorácz, O., Fésüs, A., Majoros, L., Szarka, K., Kardos, G.: Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
Microbiol. Immunol. 60 (5), 285-294, 2016.

Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.

Jakab, Á., Antal, K., Emri, T., Boczonádi, I., Imre, A., Gebri, E., Majoros, L., Pfliegler, V., Szarka, M., Balla, G., Balla, J., Pócsi, I.: Effects of hemin, CO2, and pH on the branching of Candida albicans filamentous forms.
Acta Microbiol. Immunol. Hung. 63 (4), 387-403, 2016.

Domán, M., Kovács, R., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Kardos, T., Saleh, Q., Majoros, L.: Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.

Bozó, A., Domán, M., Majoros, L., Kardos, G., Varga, I., Kovács, R.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
J. Microbiol. 54 (11), 753-760, 2016.

Kovács, R., Bozó, A., Nagy, F., Tóth, Z., Majoros, L.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Acta Microbiol. Immunol. Hung. 64 16, 2016.

Jakab, Á., Emri, T., Sipos, L., Kiss, Á., Kovács, R., Dombrádi, V., Kemény-Beke, Á., Balla, J., Majoros, L., Pócsi, I.: Betamethasone augments the antifungal effect of menadione-towards a novel anti-combination therapy.
J. Basic Microbiol. 55 (8), 973-981, 2015.

Domán, M., Kovács, R., Perlin, D., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Majoros, L.: Dose escalation studies with caspofungin against Candida glabrata.
J. Med. Microbiol. 64 (9), 998-1007, 2015.

Kovács, R., Bozó, A., Domán, M., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.

Mózes, J., Szűcs, I., Molnár, D., Jakab, P., Fatemeh, E., Szilasi, M., Majoros, L., Orosi, P., Kardos, G.: A potential role of aminoglycoside resistance in endemic occurrence of Pseudomonas aeruginosa strains in lower airways of mechanically ventilated patients.
Diagn. Microbiol. Infect. Dis. 78 (1), 79-84, 2014.

Berényi, R., Kovács, R., Domán, M., Gesztelyi, R., Kardos, G., Juhász, B., Perlin, D., Majoros, L.: Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
New Microbiol. 37 (3), 355-362, 2014.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
J. Med. Microbiol. 63 (2), 186-194, 2014.

Kovács, R., Gesztelyi, R., Perlin, D., Kardos, G., Domán, M., Berényi, R., Majoros, L.: Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
Mycopathologia. 178 (3-4), 197-206, 2014.

Kovács, R., Czudar, A., Horváth, L., Szakács, L., Majoros, L., Kónya, J.: Serum interleukin-6 levels in murine models of Candida albicans infection.
Acta Microbiol. Immunol. Hung. 61 (1), 61-69, 2014.

Szabó, B., Majoros, L., Pappné Falusi, E., Szabó, Z., Szabó, J., Márton, I., Kelentey, B.: Studies on the possible aetiological role of different Candida species in pathogenesis of dentine caries by monitoring the calcium release from tooth particles.
Acta Microbiol Immunol Hung. 61 (1), 11-17, 2014.

Emri, T., Majoros, L., Tóth, V., Pócsi, I.: Echinocandins: production and applications.
Appl. Microbiol. Biotechnol. 97 (8), 3267-3284, 2013.

Majoros, L., Kovács, R., Berényi, R., Domán, M., Miszti, C., Kardos, G.: Effect of 50% human serum on he killing activity of micafungin against C. dubliniensis, C. lusitaniae, C. guilliermondii and C. kefyr using time-kill methodology.
Mycoses. 56 64-65, 2013.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Should echinocandin doses be increased against Candida species? An in vitro and in vivo study of caspofungin against Candida albicans, C. krusei and C. inconspicua.
Mycoses. 56 (Suppl.), 60, 2013.

Antal-Szalmás, P., Vida, A., Majoros, L., Sümegi, A., Bácsi, A., Vereb, G., Strijp, J., Kessel, K.: CD14/Fc fusion protein - an artificial antibody.
Cytometry B Clin. Cytom. 82 410, 2012.

Földi, R., Kovács, R., Gesztelyi, R., Kardos, G., Berényi, R., Juhász, B., Szilágyi, J., Mózes, J., Majoros, L.: Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.
Mycopathologia. 174 (4), 311-318, 2012.

Szilágyi, J., Földi, R., Gesztelyi, R., Bayegan, S., Kardos, G., Juhász, B., Majoros, L.: Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Chemotherapy. 58 (2), 159-164, 2012.

Földi, R., Szilágyi, J., Kardos, G., Berényi, R., Kovács, R., Majoros, L.: Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
Diagn. Microbiol. Infect. Dis. 73 (4), 338-342, 2012.

Szilágyi, J., Földi, R., Sedigh, B., Kardos, G., Majoros, L.: Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.
J. Chemother. 24 (1), 18-25, 2012.

Vida, A., Bardoel, B., Milder, F., Majoros, L., Sümegi, A., Bácsi, A., Vereb, G., Kessel, K., Strijp, J., Antal-Szalmás, P.: Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.
Immunol. Lett. 146 (1-2), 31-39, 2012.

Ádám, C., Erdei, É., Casado, C., Kovács, L., Gonzalez, A., Majoros, L., Petrényi, K., Bagossi, P., Farkas, I., Molnár, M., Pócsi, I., Ariño, J., Dombrádi, V.: Protein phosphatase CaPpz1 is involved in cation homeostasis, cell wall integrity and virulence of Candida albicans.
Microbiology (Reading, Engl.). 158 (5), 1258-1267, 2012.

Bayegan, S., Szilágyi, J., Kemény-Beke, Á., Földi, R., Kardos, G., Gesztelyi, R., Juhász, B., Adnan, A., Majoros, L.: Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.
J. Chemother. 23 (2), 107-109, 2011.

Fejes, Z., Mándi, A., Komáromi, I., Majoros, L., Batta, G., Herczegh, P.: A synthetic and in silico study on the highly regioselective Diels-Alder reaction of the polyenic antifungal antibiotics natamycin and flavofungin.
Tetrahedron Lett. 51 (38), 4968-4971, 2010.

Grenczer, M., Zsuga, J., Majoros, L., Pintér, Á., Kemény-Beke, Á., Juhász, B., Tósaki, Á., Gesztelyi, R.: Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
Can. J. Physiol. Pharmacol. 88 (11), 1074-1083, 2010.

Tavanti, A., Hensgens, L., Mogavero, S., Majoros, L., Senesi, S., Campa, M.: Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.
BMC Microbiol. 10 203, 2010.

Szabó, Z., Borbély, Á., Kardos, G., Somogyvári, F., Kemény-Beke, Á., Asztalos, L., Rozgonyi, F., Majoros, L.: In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
Mycoses. 53 (3), 196-199, 2010.

Bayegan, S., Majoros, L., Kardos, G., Kemény-Beke, Á., Miszti, C., Kovács, R., Gesztelyi, R.: In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin.
J. Microbiol. 48 (2), 170-173, 2010.

Kovács, L., Farkas, I., Majoros, L., Miskei, M., Pócsi, I., Dombrádi, V.: The polymorphism of protein phosphatase Z1 gene in Candida albicans.
J. Basic Microbiol. 50 (Suppl.), S74-S82, 2010.

Varga, I., Sóczó, G., Kardos, G., Kemény-Beke, Á., Kelentey, B., Márton, I., Majoros, L.: Differences in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
J. Chemother. 21 (1), 36-41, 2009.

Szabó, Z., Szilágyi, J., Tavanti, A., Kardos, G., Rozgonyi, F., Bayegan, S., Majoros, L.: In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
Diagn. Microbiol. Infect. Dis. 64 (3), 283-288, 2009.

Varga, I., Sóczó, G., Kardos, G., Borbély, Á., Szabó, Z., Kemény-Beke, Á., Majoros, L.: Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis.
J. Antimicrob. Chemother. 62 (6), 1466-1468, 2008.

Szabó, Z., Lajszné Tóth, B., Kovács, M., Kardos, G., Maráz, A., Rozgonyi, F., Majoros, L.: Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification.
J. Clin. Microbiol. 46 (5), 1824-1825, 2008.

Majoros, L., Kardos, G.: Fungicidal activity of azole antifungal agents.
Anti-Infect. Agents Med. Chem. 7 (2), 118-125, 2008.

Fekete, A., Pócsi, I., Emri, T., Gyetvai, Á., Gazdag, Z., Pesti, M., Karányi, Z., Majoros, L., Gergely, L., Pócsi, I.: Physiological and morphological characterization of tert-butylhydroperoxide tolerant Candida albicans mutants.
J. Basic Microbiol. 48 (6), 480-487, 2008.

Varga, I., Sóczó, G., Kardos, G., Majoros, L.: Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
J. Antimicrob. Chemother. 62 (1), 149-152, 2008.

Sóczó, G., Kardos, G., McNicholas, P., Balogh, É., Gergely, L., Varga, I., Kelentey, B., Majoros, L.: Correlation of posaconazole minimum fungicidal concentration and time-kill test against nine Candida species.
J. Antimicrob. Chemother. 60 (5), 1004-1009, 2007.

Sóczó, G., Kardos, G., Varga, I., Kelentey, B., Gesztelyi, R., Majoros, L.: In vitro study of candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
Antimicrob. Agents Chemother. 51 (12), 4474-4476, 2007.

Sóczó, G., Kardos, G., McNicholas, P., Falusi, E., Gergely, L., Majoros, L.: Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Mycoses. 50 (3), 178-182, 2007.

Alberth, M., Majoros, L., Kovalecz, G., Borbás, E., Szegedi, I., Márton, I., Kiss, C.: Significance of oral Candida infections in children with cancer.
Pathol. Oncol. Res. 12 (4), 237-241, 2006.

Majoros, L., Szegedi, I., Kardos, G., Erdész, C., Kónya, J., Kiss, C.: Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study.
Eur. J. Clin. Microbiol. Infect. Dis. 25 (12), 803-806, 2006.

Majoros, L., Kardos, G., Szabó, G., Sipiczki, M.: Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
Antimicrob. Agents Chemother. 49 (8), 3486-3488, 2005.

Majoros, L., Kardos, G., Feiszt, P., Szabó, B.: Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
J. Antimicrob. Chemother. 56 (1), 253-254, 2005.

Majoros, L., Kardos, G., Szabó, B., Kovács, M., Maráz, A.: Fluconazole susceptibility testing of Candida inconspicua clinical isolates: comparison of four methods.
J. Antimicrob. Chemother. 55 (2), 275-276, 2005.

Farkas, I., Ádám, C., Molnár, G., Kovács, L., Majoros, L., Aradi, J., Dombrádi, V.: Molecular characterization of the PPZ1 gene from Candida albicans.
FEBS J. 272 (Suppl1), 511, 2005.

Sugita, T., Takeo, K., Ohkusu, M., Virtudazo, E., Takashima, M., Asako, E., Ohshima, F., Harada, C., Nishikawa, A., Majoros, L., Sipiczki, M.: Fluconazole-resistant pathogens Candida inconspicus and C. norvegicus: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility and extracellular enzyme production.
Microbiol. Immunol. 48 761-766, 2004.

Barta, Z., Csípő, I., Mekkel, G., Zeher, M., Majoros, L., Bernstein, C., Collins, M.: Seroprevalence of Mycobacterium paratuberculosis in Patients with Crohn's Disease.
J. Clin. Microbiol. 42 (11), 5432-5433, 2004.

Majoros, L., Kardos, G., Belak, A., Maráz, A., Asztalos, L., Csánky, E., Barta, Z., Szabó, B.: Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures.
J. Clin. Microbiol. 41 (11), 5250-5253, 2003.

Majoros, L., Kardos, G., Pócsi, I., Szabó, B.: Distribution and susceptibility of Candida species isolated in the Medical University of Debrecen.
Acta Microbiol. Immunol. Hung. 49 (2-3), 351-361, 2002.

Pócsi, I., Sámi, L., Leiter, É., Majoros, L., Szabó, B., Emri, T., Pusztahelyi, T.: Searching for new-type antifungal drugs.
Acta Microbiol Immunol Hung. 48 (3), 533-543, 2001.